AVALYN PHARMACEUTICALS INC

Historical 13F Holders

Symbol
AVLN
CUSIP
05348Y105
All holders as of
Q2 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 05348Y105 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
13.2% 8/6/2026
Event 6/30/2026
Novo Holdings A/S 13G 8.8% 8/14/2026
Event 6/30/2026
SR One Capital Management, LLC 13D
7.5% 5/8/2026
Event 5/1/2026
Perceptive Advisors LLC 13G
6.0% 5/7/2026
Event 4/30/2026
Suvretta Capital Management, LLC 13D
5.6% 5/8/2026
Event 5/1/2026
Norwest Venture Partners XV, LP 13G
5.1% 8/11/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 32.0 $912.00
2026 Q2 94 44.3 M $1.46 B